Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

NOD2 mutations and anti-Saccharomyces cerevisiae antibodies are risk factors for Crohn's disease in African Americans.

Dassopoulos T, Nguyen GC, Talor MV, Datta LW, Isaacs KL, Lewis JD, Gold MS, Valentine JF, Smoot DT, Harris ML, Oliva-Hemker M, Bayless TM; NIDDK IBD Genetics Consortium., Burek CL, Brant SR.

Am J Gastroenterol. 2010 Feb;105(2):378-86. doi: 10.1038/ajg.2009.575. Epub 2009 Oct 13.

2.

Antibodies to saccharomyces cerevisiae in Crohn's disease: higher titers are associated with a greater frequency of mutant NOD2/CARD15 alleles and with a higher probability of complicated disease.

Dassopoulos T, Frangakis C, Cruz-Correa M, Talor MV, Burek CL, Datta L, Nouvet F, Bayless TM, Brant SR.

Inflamm Bowel Dis. 2007 Feb;13(2):143-51.

PMID:
17206688
3.

Phenotypic associations of Crohn's disease with antibodies to flagellins A4-Fla2 and Fla-X, ASCA, p-ANCA, PAB, and NOD2 mutations in a Swiss Cohort.

Schoepfer AM, Schaffer T, Mueller S, Flogerzi B, Vassella E, Seibold-Schmid B, Seibold F.

Inflamm Bowel Dis. 2009 Sep;15(9):1358-67. doi: 10.1002/ibd.20892.

4.

Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations.

Walker LJ, Aldhous MC, Drummond HE, Smith BR, Nimmo ER, Arnott ID, Satsangi J.

Clin Exp Immunol. 2004 Mar;135(3):490-6.

5.

Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients.

Papp M, Altorjay I, Norman GL, Shums Z, Palatka K, Vitalis Z, Foldi I, Lakos G, Tumpek J, Udvardy ML, Harsfalvi J, Fischer S, Lakatos L, Kovacs A, Bene L, Molnar T, Tulassay Z, Miheller P, Veres G, Papp J; Hungarian IBD Study Group., Lakatos PL.

Inflamm Bowel Dis. 2007 Aug;13(8):984-92.

PMID:
17417801
6.

Variants of NOD1 and NOD2 genes display opposite associations with familial risk of Crohn's disease and anti-saccharomyces cerevisiae antibody levels.

Vasseur F, Sendid B, Jouault T, Standaert-Vitse A, Dubuquoy L, Francois N, Gower-Rousseau C, Desreumaux P, Broly F, Vermeire S, Colombel JF, Poulain D.

Inflamm Bowel Dis. 2012 Mar;18(3):430-8. doi: 10.1002/ibd.21817. Epub 2011 Jul 7.

PMID:
21739538
7.

Pattern recognition receptor and autophagy gene variants are associated with development of antimicrobial antibodies in Crohn's disease.

Murdoch TB, Xu W, Stempak JM, Landers C, Targan SR, Rotter JI, Silverberg MS.

Inflamm Bowel Dis. 2012 Sep;18(9):1743-8. doi: 10.1002/ibd.22884. Epub 2012 Jan 24.

8.

3020insC insertion in NOD2/CARD15 gene, a prevalent variant associated with anti-Saccharomyces cerevisiae antibodies and ileal location of Crohn's disease in Tunisian population.

Marrakchi R, Bougatef K, Moussa A, Ouerhani S, Khodjet-el-Khil H, Messai Y, Mestiri O, Najar T, Benammar-Elgaaeid A.

Inflamm Res. 2009 Apr;58(4):218-23. doi: 10.1007/s00011-008-8139-x.

PMID:
19184350
9.

CARD15 polymorphisms are associated with anti-Saccharomyces cerevisiae antibodies in caucasian Crohn's disease patients.

Cruyssen BV, Peeters H, Hoffman IE, Laukens D, Coucke P, Marichal D, Cuvelier C, Remaut E, Veys EM, Mielants H, De Vos M, De Keyser F.

Clin Exp Immunol. 2005 May;140(2):354-9.

10.

Role of ASCA and the NOD2/CARD15 mutation Gly908Arg in predicting increased surgical costs in Crohn's disease patients: a project of the European Collaborative Study Group on Inflammatory Bowel Disease.

Odes S, Friger M, Vardi H, Claessens G, Bossuyt X, Riis L, Munkholm P, Wolters F, Yona H, Hoie O, Beltrami M, Tsianos E, Katsanos K, Mouzas I, Clofent J, Monteiro E, Messori A, Politi P, O'Morain C, Limonard C, Russel M, Vatn M, Moum B, Stockbrugger R, Vermeire S; European Collaborative Study Group on Inflammatory Bowel disease..

Inflamm Bowel Dis. 2007 Jul;13(7):874-81.

PMID:
17278126
11.

Predicting complicated Crohn's disease and surgery: phenotypes, genetics, serology and psychological characteristics of a population-based cohort.

Ryan JD, Silverberg MS, Xu W, Graff LA, Targownik LE, Walker JR, Carr R, Clara I, Miller N, Rogala L, Bernstein CN.

Aliment Pharmacol Ther. 2013 Aug;38(3):274-83. doi: 10.1111/apt.12368. Epub 2013 Jun 3.

12.

Disease location, anti-Saccharomyces cerevisiae antibody, and NOD2/CARD15 genotype influence the progression of disease behavior in Crohn's disease.

Smith BR, Arnott ID, Drummond HE, Nimmo ER, Satsangi J.

Inflamm Bowel Dis. 2004 Sep;10(5):521-8.

PMID:
15472511
13.

New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort.

Papp M, Altorjay I, Dotan N, Palatka K, Foldi I, Tumpek J, Sipka S, Udvardy M, Dinya T, Lakatos L, Kovacs A, Molnar T, Tulassay Z, Miheller P, Norman GL, Szamosi T, Papp J; Hungarian IBD Study Group., Lakatos PL.

Am J Gastroenterol. 2008 Mar;103(3):665-81. Epub 2007 Nov 28.

PMID:
18047543
14.

Pancreatic autoantibodies are associated with reactivity to microbial antibodies, penetrating disease behavior, perianal disease, and extraintestinal manifestations, but not with NOD2/CARD15 or TLR4 genotype in a Hungarian IBD cohort.

Lakatos PL, Altorjay I, Szamosi T, Palatka K, Vitalis Z, Tumpek J, Sipka S, Udvardy M, Dinya T, Lakatos L, Kovacs A, Molnar T, Tulassay Z, Miheller P, Barta Z, Stocker W, Papp J, Veres G, Papp M; Hungarian IBD Study Group..

Inflamm Bowel Dis. 2009 Mar;15(3):365-74. doi: 10.1002/ibd.20778.

PMID:
18972554
15.
16.

A prospective comparative study of ASCA and pANCA in Chinese and Caucasian IBD patients.

Lawrance IC, Murray K, Hall A, Sung JJ, Leong R.

Am J Gastroenterol. 2004 Nov;99(11):2186-94.

PMID:
15555001
17.

Anti-Saccharomyces cerevisiae antibodies status is associated with oral involvement and disease severity in Crohn disease.

Russell RK, Ip B, Aldhous MC, MacDougall M, Drummond HE, Arnott ID, Gillett PM, McGrogan P, Weaver LT, Bisset WM, Mahdi G, Wilson DC, Satsangi J.

J Pediatr Gastroenterol Nutr. 2009 Feb;48(2):161-7. doi: 10.1097/MPG.0b013e318183e112.

PMID:
19179877
18.

Common NOD2 risk variants in African Americans with Crohn's disease are due exclusively to recent Caucasian admixture.

Adeyanju O, Okou DT, Huang C, Kumar A, Sauer C, Galloway C, Prasad M, Waters J, Cutler DJ, Zwick ME, Dhere T, Kugathasan S.

Inflamm Bowel Dis. 2012 Dec;18(12):2357-9. doi: 10.1002/ibd.22944. Epub 2012 Mar 22.

19.

Anti-Saccharomyces cerevisiae antibodies in twins with inflammatory bowel disease.

Halfvarson J, Standaert-Vitse A, Järnerot G, Sendid B, Jouault T, Bodin L, Duhamel A, Colombel JF, Tysk C, Poulain D.

Gut. 2005 Sep;54(9):1237-43. Epub 2005 Apr 29.

20.

Anti-Saccharomyces cerevisiae antibodies associate with phenotypes and higher risk for surgery in Crohn's disease: a meta-analysis.

Zhang Z, Li C, Zhao X, Lv C, He Q, Lei S, Guo Y, Zhi F.

Dig Dis Sci. 2012 Nov;57(11):2944-54. doi: 10.1007/s10620-012-2244-y. Epub 2012 Jun 6.

PMID:
22669207

Supplemental Content

Support Center